First-in-human study finds novel immune cell therapy is safe and effective in advanced lymphoma

MD Anderson Cancer Center's first-in-human study shows novel immune cell therapy RB-1355 is safe and effective for advanced lymphomas, offering new hope for patients who relapsed or did not respond to standard treatments.